.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Accenture
Colorcon
Harvard Business School
AstraZeneca
UBS
Argus Health
Fuji
Dow
Mallinckrodt

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018147

« Back to Dashboard
NDA 018147 describes FELDENE, which is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. Additional details are available on the FELDENE profile page.

The generic ingredient in FELDENE is piroxicam. There are fifteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

Summary for NDA: 018147

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 018147

Suppliers and Packaging for NDA: 018147

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FELDENE
piroxicam
CAPSULE;ORAL 018147 NDA Pfizer Laboratories Div Pfizer Inc 0069-3220 0069-3220-66 100 CAPSULE in 1 BOTTLE (0069-3220-66)
FELDENE
piroxicam
CAPSULE;ORAL 018147 NDA Pfizer Laboratories Div Pfizer Inc 0069-3230 0069-3230-66 100 CAPSULE in 1 BOTTLE (0069-3230-66)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Apr 6, 1982TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Apr 6, 1982TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 018147

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-003Apr 6, 1982RE29668► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,674,876► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-003Apr 6, 19823,862,319► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,927,002► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,591,564► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
Queensland Health
AstraZeneca
Chubb
Cantor Fitzgerald
Julphar
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot